Organizing and Mobilizing the United States Government To Provide a Unified and Effective Response To Combat COVID-19 and To Provide United States Leadership on Global Health and Security

This executive order establishes a White House COVID-19 Response Coordinator and Deputy Coordinator to unify federal pandemic response efforts, including vaccine distribution, testing expansion, PPE production, and school reopening support. It also creates an NSC Directorate on Global Health Security and Biodefense, assigns the APNSA responsibility for national biodefense preparedness, and mandates a 180-day review of biological threats and biopreparedness policies.

Federal Register Open PDF 86 FR 7019

Impact dates

Jul 19, 2021
APNSA completes review of biological risks and biopreparedness policies with recommendations to President

Key directives

Establish COVID-19 Response Coordinator reporting directly to President
Establish Deputy Coordinator of the COVID-19 Response
Create NSC Directorate on Global Health Security and Biodefense headed by Senior Director
Reconvene Global Health Security Agenda Interagency Review Council
Assign APNSA responsibility for coordinating national biodefense preparedness
APNSA to complete review of biological risks and biopreparedness policies within 180 days
Agency heads to report procedural/legal/funding obstacles to Coordinator immediately

Who is ordered

Timeline

Immediate

Establishment of COVID-19 Response Coordinator and Deputy Coordinator positions
Creation of NSC Directorate on Global Health Security and Biodefense
Agency heads directed to report obstacles to COVID-19 response

Near term (90d)

Coordinator to begin organizing government-wide response on disparities, PPE, testing, vaccines, and school reopening
APNSA to convene NSC Principals Committee as needed for global health security

Long term

180-day review of biological risks and biopreparedness policies due
Framework development for pandemic readiness triggers and federal-state coordination
Ongoing global health security and biodefense institutional structures

Risks & tensions

No dedicated funding appropriated; implementation 'subject to availability of appropriations' per Section 5(b)
Potential overlap or tension between COVID-19 Response Coordinator and APNSA responsibilities on pandemic response vs. biodefense
Vague 'as soon as practicable' and 'immediately' language for agency obstacle reporting lacks enforcement mechanism
Reassignment of biodefense coordination from NSPM-14 to APNSA may create institutional friction